SE9704463D0 - Novel auto antigen - Google Patents
Novel auto antigenInfo
- Publication number
- SE9704463D0 SE9704463D0 SE9704463A SE9704463A SE9704463D0 SE 9704463 D0 SE9704463 D0 SE 9704463D0 SE 9704463 A SE9704463 A SE 9704463A SE 9704463 A SE9704463 A SE 9704463A SE 9704463 D0 SE9704463 D0 SE 9704463D0
- Authority
- SE
- Sweden
- Prior art keywords
- relates
- tryptophan hydroxylase
- kit
- autoimmune
- novel auto
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a reagent and kit for assaying antibodies against a novel autoantigen, tryptophan hydroxylase. The kit is especially suited for diagnosis of gastrointestinal dysfunction, e.g. in APS I (autoimmune polyendocrine syndrome, type I) patients. Furthermore, the invention relates to tryptophan hydroxylase as a drug target in the production of drugs for the treatment of autoimmune diseases. The invention also relates to a method for treating patients having an autoimmune disease. The method is characterized by the administration of a drug interacting with tryptophan hydroxylase or parts thereof.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704463A SE9704463D0 (en) | 1997-11-28 | 1997-11-28 | Novel auto antigen |
AU15168/99A AU1516899A (en) | 1997-11-28 | 1998-11-27 | Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment |
PCT/SE1998/002171 WO1999028753A1 (en) | 1997-11-28 | 1998-11-27 | Application of tryptophan hydroxylase, a novel autoantigen, in immunoassays, drug production and treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9704463A SE9704463D0 (en) | 1997-11-28 | 1997-11-28 | Novel auto antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9704463D0 true SE9704463D0 (en) | 1997-11-28 |
Family
ID=20409209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9704463A SE9704463D0 (en) | 1997-11-28 | 1997-11-28 | Novel auto antigen |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1516899A (en) |
SE (1) | SE9704463D0 (en) |
WO (1) | WO1999028753A1 (en) |
-
1997
- 1997-11-28 SE SE9704463A patent/SE9704463D0/en unknown
-
1998
- 1998-11-27 AU AU15168/99A patent/AU1516899A/en not_active Abandoned
- 1998-11-27 WO PCT/SE1998/002171 patent/WO1999028753A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999028753A1 (en) | 1999-06-10 |
AU1516899A (en) | 1999-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69922261D1 (en) | MONOCLONAL ANTIBODIES, ANTIGENS AND DIAGNOSIS AND THERAPY OF VICIOUS DISEASES | |
EA200700083A1 (en) | ANTIBODIES DIRECTED AGAINST BETA AMYLOID PEPTIDE, AND METHODS OF THEIR APPLICATION | |
JP2005506947A5 (en) | ||
DE60235746D1 (en) | Antibody to Alzheimer specific tau proteins with abnormal conformation | |
ES2120416T3 (en) | TUMOR GROWTH INHIBITORS DERIVED FROM TISSUES, PREPARATION METHODS AND USES OF THESE INHIBITORS. | |
BR0206160A (en) | Use of anti-TNF antibodies as medicines in the treatment of septic disorders of anemic patients. | |
RU2005134354A (en) | ANTIBODIES AGAINST MONOCITARY CHEMOATTRACTANT, PROTEIN-1, (MCP-1) AND THEIR APPLICATION | |
Shmuel‐Galia et al. | Neutralization of pro‐inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis | |
BRPI0510883A (en) | conjugated drug and antibody compound, pharmaceutical composition, cell proliferation inhibition methods, cancer treatment, tumor cell growth inhibition and dysfunction-sensitive human patient treatment, cancer cell detection test, industrialized article and method drug and antibody conjugate manufacturing | |
MA29346B1 (en) | Gastroresistant pharmaceutical formulations based on rifaximin | |
EA200801071A1 (en) | METHODS AND COMPOSITIONS FOR APPLICATION FOR THE TREATMENT OF PATIENTS WITH POSITIVE ON AUTOANTIBODIES DISEASE | |
HUP0102193A2 (en) | Glucagon-like peptide-1 improves betha-cell response to glucose in subjects with impaired glucose tolerance | |
DE69010206D1 (en) | STABILIZED PROTEIN OR PEPTIDE CONJUGATES. | |
ATE493978T1 (en) | TREATMENT OF AUTOIMMUNE DISEASES | |
DE59705683D1 (en) | IMMUNOLOGICAL DETECTION METHOD OF ANTIBODIES TARGETED AGAINST TISSUE TRANSGLUTAMINASE (tTG), USE OF tTG FOR DIAGNOSIS AND THERAPY CONTROL, AND ORAL PHARMACEUTICAL AGENT CONTAINING tTG | |
EP2147928A3 (en) | Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein | |
WO2001054681A8 (en) | Composition for treatment of stress | |
NZ542866A (en) | Compositions and methods for the therapy of inflammatory bowel disease | |
JP2004538477A5 (en) | ||
DE60129278D1 (en) | Antibodies directed against the SEMP1 protein, process for their preparation, and their uses | |
MA30665B1 (en) | TREATMENT OF RHEUMATOID DISEASES WITH DELAYED RELEASE GLUCOCORTICOIDS. | |
SE9704463D0 (en) | Novel auto antigen | |
WO2002094199A3 (en) | METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD | |
Parker et al. | Allergic drug responses-mechanisms and unsolved problems | |
WO2005097183A3 (en) | Treatment of diseases |